Malnutrition and muscle wasting are frequently reported in cancer patients, either linked to
the tumor itself or caused by oncologic therapies. Understanding the value of nutritional care …

Objective: To investigate the association between pretreatment prognostic nutritional index
(PNI) and clinical survival outcomes for advanced-stage cancer patients treated with …

Objectives Combination therapy of immune checkpoint inhibitors and chemotherapy is
considered to be one of the standard treatment options for patients with advanced non-small …

Introduction Association of high body mass index (BMI) with longer survival has been
reported in patients on immune checkpoint inhibitors (ICIs), but results are inconsistent. This …

Introduction Pembrolizumab is an established first-line option for patients with advanced non-
small-cell lung cancer (NSCLC) expressing programmed death-ligand 1≥ 50%. Durable …

Simple Summary Tumors of head and neck cancer are a heterogenous collection of
malignancies affecting the upper aerodigestive tract, the majority of which are head and …

Malnutrition is a frequent problem in cancer patients, which leads to prolonged and repeated
hospitalizations, increased treatment-related toxicity, reduced response to cancer treatment …

Malnutrition is a frequent comorbidity in head and neck cancer patients and has been shown
to impair immunotherapy response in other cancer types. The geriatric nutritional risk index …

Background Peripheral blood-based biomarkers (PBB) predicting response, survival and
immune-related adverse events (irAEs) in patients with advanced non-small cell lung cancer …

Background Prognostic nutritional index (PNI) has been identified as a reliable prognostic
factor for cancer adjuvant therapy. However, its prognostic value in lung cancer patients …